PMID: 7029260Oct 1, 1981Paper

Human saliva inactivates mutagenicity of carcinogens

Mutation Research
H NishiokaK Kyokane

Abstract

Mutagenicities of AF-2, MNNG, 4NQO, aflatoxin B1, benzo [a] pyrene and Trp-P-1, with or without metabolic activation, were inactivated by treatment with human saliva to a great extent in the Ames test with Salmonella typhimurium test strains TA98 and TA100. Mutagenic activities of quercetin, pyrolysates of beef, salmon and sodium glutamate, and condensate of cigarette smoke were also decreased to some extent by saliva treatment, but no significant effect was found on the activity of MMS and pyrolysate of polypeptone. These effects showed individual variations. The inhibition of AF-2 mutagenicity by saliva varied with temperature in TA100 but not in TA98 cultures. Boiled saliva inactivated AF-2 mutagenicity in TA98 to some extent but not in TA100 cultures. Inactivation of AF-2 mutagenicity by saliva treatment was completed within 30 sec. Complex mechanisms may be involved in the inactivation of mutagenicity of carcinogens by saliva, including biochemical reactions with enzymes, vitamins, etc. and/or adsorption with high molecular weight substances in saliva such as proteins, bacterial cells, mucous materials, etc.

References

May 1, 1977·Cancer Letters·M NagaoT Kawachi
Nov 1, 1978·Mutation Research·Y SeinoS Nishimura
Jan 1, 1977·Mutation Research·J L EplerA A Hardigree
Nov 1, 1975·Cancer Letters·T YahagiM Nagao

❮ Previous
Next ❯

Citations

Jul 1, 2001·Environmental Health and Preventive Medicine·M TodaK Sugawara
Apr 1, 2002·Environmental Health and Preventive Medicine·Masahiro TodaKazuo Hayakawa
Apr 1, 2002·Environmental Health and Preventive Medicine·Masahiro TodaKazuo Hayakawa
Dec 26, 2009·European Journal of Applied Physiology·A DamirchiReyhaneh Sariri
Oct 13, 2006·Clinical Oral Investigations·Mala Kamboj, Sumita Mahajan
Jan 1, 1988·Mutation Research·T Gichner, J Velemínský
Jan 1, 1985·Mutation Research·M Protić-SabljićK H Kraemer
Sep 1, 1987·Mutation Research·T Nunoshiba, H Nishioka
Feb 6, 2002·Free Radical Biology & Medicine·Rafael M NaglerAbraham Z Reznick
Jan 25, 2003·Free Radical Biology & Medicine·Abraham Z ReznickRafael M Nagler
Mar 1, 1997·Oral Oncology·D DayanL Bodner
Jan 12, 2001·Mutation Research·F KassieS Knasmüller
Jun 28, 2003·Best Practice & Research. Clinical Gastroenterology·Frank RiedelKarl Hörmann
Apr 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Oded HershkovichRafael M Nagler
Dec 22, 2004·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Yelda KarincaogluMetin Genc
Dec 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Michael D JohnsonPeter G Shields
Jul 15, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Oded HershkovichRafael M Nagler
Dec 1, 1984·Journal of Oral Pathology·J Tenovuo, K M Pruitt
Mar 21, 2006·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Antonia SiogaKostantinos Antoniades
Nov 4, 2005·Oral Oncology·B MognettiG N Berta
Aug 1, 1989·The Journal of the American Dental Association·I D Mandel
Mar 26, 2004·HNO·F Riedel, K Hörmann
Mar 2, 2006·Digestive Diseases·Frank RiedelKarl Hormann
May 27, 2004·British Journal of Cancer·A Z ReznickR M Nagler
Mar 25, 2019·International Journal of Molecular Sciences·Marcin MagaczWirginia Krzyściak
Nov 30, 2019·Journal of Clinical Biochemistry and Nutrition·Tomoko KomatsuMasaichi Chang-Il Lee
Feb 1, 1987·Journal of Dental Research·I D Mandel
Sep 2, 2020·Journal of Applied Microbiology·H PanwarA K Puniya
Oct 2, 2003·The Journal of Nutrition·Jeremy P E Spencer
Feb 14, 2013·The Journal of Contemporary Dental Practice·Yasmeen F ZubairyShankargouda Patil

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.